Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
87,819,638
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
21,268,922
-
Shares change
-
+10,164,423
-
Total reported value, excl. options
-
$28,723,974
-
Value change
-
+$14,962,053
-
Number of buys
-
53
-
Number of sells
-
-11
-
Price
-
$1.35
Significant Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q3 2025
75 filings reported holding CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q3 2025.
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,268,922 shares
of 87,819,638 outstanding shares and own 24% of the company stock.
Largest 10 shareholders include BIOS Capital Management, LP (6,000,000 shares), DAVENPORT & Co LLC (2,689,336 shares), VANGUARD GROUP INC (2,681,613 shares), TANG CAPITAL MANAGEMENT LLC (1,200,000 shares), Chescapmanager LLC (997,029 shares), BlackRock, Inc. (968,699 shares), JANE STREET GROUP, LLC (926,150 shares), RENAISSANCE TECHNOLOGIES LLC (713,500 shares), GEODE CAPITAL MANAGEMENT, LLC (712,727 shares), and Hilton Capital Management, LLC (581,150 shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.